SPOTLIGHT -
App helps diabetes patients better engage in their care
Constant communication and education are critical to help patients manage their diabetes symptoms and avoid costly complications.
The role of continuous glucose monitoring in diabetes management
CGM has many benefits and can improve disease management in both Type 1 (diabetes) and Type 2 diabetes. One thing CGM does very well is provide instant feedback on lifestyle choices.
Continuity of primary care helps chronic kidney disease patients
Relationships key to managing complexities, comorbidities, study finds.
Young adults with prediabetes more likely to be hospitalized for heart attacks
Study focuses on risk factors for those aged 18 to 44 years.
Record high drug overdoses ‘ravaging’ United States, physicians say
AMA cites need for treatments, naloxone, supportive policies.
Worldwide analysis ‘a major step’ in understanding genetics of Type 2 diabetes
Findings include 40 genes never reported, from diverse population base.
Researchers warn against national strategies for new normal with COVID-19
Talks of new normal fail to incorporate lessons from two years of COVID
ACP supports Biden’s 2022 National Drug Control Strategy
“Mismatch” with opioid treatment, vulnerable communities, leaves patients at risk in disaster
Study examines locations, preparedness for pandemic, treatment disruptions.
Physicians need more info on e-cigarettes to communicate with patients
Devices could help patients reduce or stop using tobacco, researchers say.
Data shows long COVID hitting women more than men
Researchers just now starting to get an idea of who is more likely to suffer from long COVID
Teen overdose deaths spike due to fentanyl during COVID-19 pandemic
Exponential rise in death rate is historic, even as adolescent drug use is low.
Physicians and payers must embrace next-generation genetic sequencing
Genomic sequencing can identify genetic variants that may eventually lead to diseases or increase an individual’s risk of developing a specific disease.
FDA authorizes second booster for those 50 or older
Evidence suggests a second booster improve protection against severe COVID
Teens, older adults not getting medications to treat opioid abuse
Insurance a factor in access to drug treatments, a new study said.
New principal care management codes: What physicians need to know
Four new codes have been put in place in 2022.
Stop the stigma of weight bias
Physicians have a role in stamping out weight bias.
Lawmakers gaining awareness for long COVID-19 relief, physicians group says
Could be new challenge for Social Security, analyst says
Exercise shows promise against long COVID
May stop cycle of inflammation that can lead to diabetes and depression
Seniors with dementia may have too many medications prescribed
Over-medicating may lead to adverse drug interactions and make their dementia worse
The economic costs of obesity
How to overcome the rising costs of obesity
Nonprofit Civica announces plan for affordable insulins
Pending FDA approval, could be available in 2024.
Vaccination divide between rural and urban areas continues to increase
Rural areas lag well behind their urban counterparts when it comes to COVID-19 vaccinations
What is precision medicine?
Treatment with direct-acting antivirals improves outcomes for hepatitis C patients
The results are published online in Clinical Infectious Diseases.
Proposed opioid guidelines would remove hard prescribing caps, rely on clinical judgement
The CDC is seeking comment on the voluntary guidelines, which come on the heels of the controversial 2016 guidance that placed hard caps on prescribing.
Report: New antibacterial drugs lag in development and investment
Big pharma and investors focusing on other segments despite the need for new therapeutics
The 7 new drugs expected to hit $1 billion in sales in five years
These drugs treat everything from cancer to cognitive decline.
FDA approves HIV pre-exposure preventive injection
Apretude is approved for use in at-risk adults and adolescent to reduce the risk of sexually acquired HIV.
CDC recommends Moderna and Pfizer in adults over Johnson & Johnson
Blood clot risk in J&J higher for women, draws CDC concerns
